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ABSTRACT: Promoters are key components of cell factory
design, allowing precise expression of genes in a heterologous
pathway. Several commonly used promoters in yeast cell
factories belong to glycolytic genes, highly expressed in
actively growing yeast when glucose is used as a carbon
source. However, their expression can be suboptimal when
alternate carbon sources are used, or if there is a need to
decouple growth from production. Hence, there is a need for
alternate promoters for diﬀerent carbon sources and
production schemes. In this work, we demonstrate a reversal
of regulatory function in two glycolytic yeast promoters by replacing glycolytic regulatory elements with ones induced by the
diauxic shift. We observe a shift in induction from glucose-rich to glucose-poor medium without loss of regulatory activity, and
strong ethanol induction. Applications of these promoters were validated for expression of the vanillin biosynthetic pathway,
reaching production of vanillin comparable to pathway designs using strong constitutive promoters.
KEYWORDS: transcriptome, synthetic promoter, glycolysis, gluconeogenesis, vanillin
The budding yeast Saccharomyces cerevisiae is a popular cellfactory platform, with several genetic and molecular tools
available to facilitate the production of compounds of interest
for the chemical and pharmaceutical industry. The synthesis of
increasingly complex molecules, in turn, require successful
construction of large and complex heterologous pathways,1−3
which impose an added metabolic burden by competing for
required cellular resources with native metabolism. Competi-
tion for a common pool of ATP, cofactors, coenzymes and
precursors between native and heterologous pathways can
adversely aﬀect growth, lengthen fermentation, and decrease
product titers and yields.4−6 One way to avoid this problem is
to activate the production pathway after the major growth
phase. For a typical process with a fermentable carbon source,
a good regulatory trigger would be the diauxic shift following
fermentation.7,8 However, most promoters commonly used for
heterologous pathway construction are glycolytic (PGK1pr,
TPI1pr, or TDH3pr) or constitutive (TEF1pr), and lack the
desired induction properties. Native yeast promoters have been
identiﬁed for gene expression under these conditions and used
for production,7−11 yet it is unclear if suﬃcient native
promoters with suitable properties exist to be used for large
biosynthetic pathways. Therefore, using synthetic promoters
with optimal regulatory output at the diauxic shift would be
beneﬁcial for cell factory design. This can be achieved by
hybrid promoter fusion or mutagenesis,12,13 but the level of
control over regulatory signals or expression levels using these
approaches may not be suﬃcient. In previous work, we
developed a promoter engineering workﬂow to engineer yeast
promoters responsive to any environmental condition given
transcriptome or transcription factor binding site (TFBS) data,
and functional genomics for the condition of interest, if
available.14 Other studies have also made use of expression
data in a similar manner to engineer synthetic promoters and
biosensors.15,16 However, generally most work on synthetic
Saccharomyces promoters does not focus on rationally
engineering native regulatory elements to generate deﬁned
regulatory properties, as has been done in other yeasts. Having
used this workﬂow to make promoters inducible by low
extracellular pH,14 we now use the same workﬂow to design
promoters inducible by glucose starvation and alternating
carbon sources.
Using S. cerevisiae CEN.PK 113-7D transcriptome data
generated during the lag (10% glucose consumption, low
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ethanol production), mid-exponential (75% glucose consumed,
increasing ethanol production), and post-exponential phases
(>99% glucose consumed, start of ethanol consumption), we
identiﬁed genes with the desired expression proﬁle: strong
induction upon glucose depletion (see Figure 1A). Induction
under these conditions involves transcriptional activators such
as Cat8, Sip4, Rds2, and Adr1 (Table 1), clustered in carbon
source response elements (CSREs) in promoters of
interest.17−21Therefore, CSREs are relevant regulatory ele-
ments to ensure that promoters are activated at the diauxic
shift and remain activated past this shift. Transcriptome
analysis revealed 4418 diﬀerentially expressed genes (DEGs)
from the 3-way comparison, with the majority being induced
at, or following, glucose depletion and the start of diauxic shift
(26 h, as compared to 14 h), including 17 out of 19 genes
(excluding ENO2 and PYC2) associated with gluconeogenesis
(term GO:0006094) (see Figures 1B and 1C, as well as Table
S1 in the Supporting Information).
Next, we scanned the promoters for clustered TFBSs in
CSREs. However, reported sequences for their binding sites
contain palindromic or inverted repeats, as well as stretches of
ambiguous bases. For further conﬁrmation, we analyzed the
discovered TFBSs for overlap with CSREs reported in the
literature (see Table 1, as well as Table S2 in the Supporting
Information). From this analysis, we selected CSREs from
PCK1 and FBP1 as candidate elements for synthetic promoter
engineering based on three criteria: (i) promoters had a strong
induction and appeared in both gene ontology mappings (see
Table 1, as well as Figure S1 in the Supporting Information);
(ii) the CSREs have been experimentally validated in the past
in multiple studies;11,22 and (iii) while other genes had a
higher fold-induction, e.g., MLS1, the CSREs from FBP1 and
PCK1 promoters also contained the most overlapping TFBSs.
Figure 1. Yeast transcriptome analysis during lag, mid-exponential, and post-exponential phases, and engineering of diauxic responses in glycolytic
promoters. (A) Growth proﬁle of S. cerevisiae CEN.PK grown in Delft medium (black), and the corresponding glucose (dark blue) and ethanol
(red) concentrations. Black arrows indicate sampling time-points (6, 14, and 26 h) for RNaseq analysis. Measurements are mean ± SEM from three
biological replicates. [SEM = standard error of the mean.] (B) Venn diagram showing the numbers of signiﬁcantly diﬀerentially expressed genes
(DEGs) from the three-way comparison between sampling points as indicated in panel (A). (C) Heat map of triplicate expression proﬁles of 17
DEGs following the diauxic shift (14 h vs 26 h) under GO term for gluconeogenesis (GO:0006094). (D) A 200 bp UAS from TDH3pr was fused
upstream of the TDH3 core promoter, creating UAS-349, a relatively strong promoter exhibiting the same trends as intact TDH3pr with its output
decreasing over time once glucose is depleted. Replacing its Gcr1 binding sites with CSREs from gluconeogenic genes (UAS349-PCK1, UAS349-
FBP1) reverses the induction pattern, with an output stronger than the native TDH3pr once glucose is depleted. Replacing Gcr1 sites with Gis1
sites (UAS349-Gis1) does not have the same eﬀect. (E) The synthetic gluconeogenic promoters are stronger than ADH2pr, a native promoter
strongly derepressed on glucose starvation, and the commonly used TEF1pr and PGK1pr. (F) Replacing Gcr1 sites in TPI 1p with CSREs from
FBP1pr into TPI1pr cause reversal of glucose-dependent induction, even though Gcr1 sites in TPI1pr are diﬀerently spaced and oriented. For
panels (D)−(F), the dashed line indicates the time point where glucose was no longer detected, as described in the Methods section. All
measurements in panels (D)−(F) represents the mean ± SEM from three biological replicates. AU = arbitrary units. At the bottom of panels (D)−
(F), illustrations outline the schematics of the promoter engineering. The sequences of the binding sites are listed in Table S6 in the Supporting
Information, and all promoter sequences are listed in Table S7 in the Supporting Information.
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This potential redundancy of function would allow for more
reliable induction and ensure that the promoter activity would
remain activated past the diauxic shift.20,21,23 Finally, since
native PCK1 and FBP1 promoters have relative high expression
levels during the early exponential phase (see Table S1 in the
Supporting Information), these native promoters did not
themselves have desired gluconeogenic responses.
These CSREs were used to engineer a 200 bp upstream
activating sequence (UAS) from the glycolytic TDH3
promoter (TDH3pr). We chose this UAS to test the reversal
of regulatory function by TFBS exchange, because its main
regulatory elements are well-annotated and conﬁrmed by
ChIP-chip studies (Figures 1D and 1E).24 In particular, this
UAS contains all the Gcr1 binding sites in TDH3pr, and this
TF is a key regulator of glycolytic genes.25,26 It also contains
TFBSs for Rap1, which is a TF that we have previously shown
to increase promoter strength.12 It was therefore in the interest
of maintaining high expression under relevant conditions to
retain these parts of the UAS architecture, rather than swap the
TDH3pr UAS with that of PCK1pr or FBP1pr. YFP reporter
assays revealed that the UAS fused to the TDH3 core promoter
(UAS349) retained 60% of the activity of TDH3pr (see Figure
1D, as well as Figures S2 and S3 in the Supporting
Information). Replacing both Gcr1 sites and surrounding
neutral sequence with CSREs from either PCK1pr or FBP1pr
to yield promoters UAS349-PCK1 and UAS349-FBP1 (Figure
1D) did indeed shift the induction trigger of the UAS from a
glucose-rich medium to a glucose-depleted medium, with the
induction of UAS349-PCK1 and UAS349-FBP1 triggered by
glucose depletion, after ∼24 h of culture. Importantly, both
promoters had a stronger output than not only UAS349 and
but also TDH3prone of the strongest yeast promoters in
usewhich was sustained as long as glucose was not
replenished. The replacement of Gcr1 sites with CSREs was
suﬃcient and necessary for the induction. When they were
exchanged with Gis1 (a TF implicated in upregulating genes at
the stationary phase) binding sites instead (UAS349-Gis1),27
the promoter did not induce upon glucose starvation and
remained weak throughout the assay period (Figure 1D).
Ultimately, UAS349-PCK1 and UAS349-FBP1 were up to 3-
fold stronger than commonly used constitutive promoters over
long time periods (Figure 1E). A stronger switch in induction
was achieved when the Gcr1 site exchange was made for the
triose phosphate isomerase promoter (TPI1pr) with CSREs
from FBP1pr (TPI1-FBP1h; see Figure 1F, as well as Figures
S2 and S3).28 Although the orientation, spacing, and sequence
context of Gcr1 sites in both TDH3pr and TPI1pr were
diﬀerent, we observed near-identical induction behavior. It is
likely the change in induction is independent of the local
context of Gcr1 sites, provided that no other neighboring
TFBSs are modiﬁed (as was the case for TDH3pr and TPI1pr),
and that their substitution could be applied to engineer
induction switching in any glycolytic promoter. Finally, the
synthetic promoters are stronger when grown on ethanol as a
carbon source (Figure S4 in the Supporting Information). The
lack of glucose repression, and the higher levels of ethanol (2−
3-fold), compared to those built up during the growth on
glucose, probably induce them to higher levels.
To demonstrate the usefulness of our synthetic promoters,
we applied them for the design of yeast cell factories for
vanillin-β-glucoside biosynthesis (Figure 2A).29 The choice of
product was motivated by the fact that actual vanillin-β-
glucoside synthesis, when using glycolytic promoters, occurs in
the ethanol phase.30 In existing cell factories and their
fermentations, ∼70% of the carbon ends up as toxic
intermediates like protocatechuic acid (PCA), continuously
produced and largely secreted through both glucose and
ethanol phases.31,32 We used UAS349-PCK1 and UAS349-
FBP1 instead of constitutive promoters only for the enzymes
that convert PCA to vanillin (ACAR and EntD (see Figure 2A,
as well as Figure S5 in the Supporting Information), expecting
improved PCA conversion, faster growth, and ultimately
similar or higher extracellular vanillin-β-glucoside production
(Figure 2A). Compared to the existing pathway design relying
on the use of constitutive (TEF1pr) and glycolytic (PGK1pr)
promoters (C-VG) alone,30 the use of synthetic gluconeogenic
promoters to control expression of the vanillin-β-glucoside
biosynthetic pathway (strains ScASR.V001 and ScASR.V003)
supported production of vanillin-β-glucoside to similar levels as
the C-VG strain, following a 65 h fermentation (Figure 2B).
Similarly, the growth and glucose consumption rates were
increased, and conversion of PCA toward protocatechuic
aldehyde (PAL) was also improved in the engineered strains,
compared to C-VG (see Figures 2C and 2D, as well as Figures
S6−S8 in the Supporting Information). Ultimately,
ScASR.V003 produced a higher amount of vanillin-β-glucoside
as a percentage of the total heterologous extracellular
metabolites, suggesting that the CSRE from FBP1pr has the
best performance for engineering gluconeogenic promoters for
practical applications (see Figure 2D, as well as Figure S8). We
can envisage further improving PCA conversion by placing the
enzyme synthesizing it from 3-dehydroshikimate (3-DSD)
under the control of another synthetic promoter responsive to
Table 1. Genes Associated with Carbon Metabolism
Upregulated between the Log Phase and Diauxic Shift
gene
fold-
induction binding sites in CSREs
references for binding
sites
Annotated “Gluconeogenesis” by Gene Ontology
PCK1 472.97 Adr1, Cat8, Sip4, Rds2 18, 20, 23, 24
FBP1 52.67 Adr1, Cat8, Rds2 18, 20, 24
MDH2 6.55 Adr1, Cat8, Rds2 18, 20, 23
PYC1 1.87 Cat8 18, 20
GPM2 1.74 none
PYC2 1.46 none
Annotated “Carbon Metabolic Process” by GO_slim
MLS1 650.68 Adr1, Cat8, Rds2 18, 20, 24
PCK1 472.97 Adr1, Cat8, Sip4, Rds2 18, 20, 23, 24
ICL1 145.86 Cat8, Sip4 18, 19, 20, 23
YIG1 129.24 Adr1,Cat8 23
FBP1 52.67 Adr1, Cat8, Rds2 18, 20, 24
MAL12 28.48 Cat8 23
MAL11 29.81 Cat8 23
CAT8 22.31 none
MAL32 16.89 none
GAL3 13.67 Cat8 23
MDH2 6.55 Adr1, Cat8, Rds2 18, 20, 23
DAK2 6.67 none
PYC1 1.87 Cat8 18, 20
Fold-Induction of Other Native Promoters
ADH2 10.93 Cat8, Sip4 18, 19, 21
TDH3 0.163 none
TEF1 0.762 none
PGK1 0.192 Adr1 23
TPI1 0.0732 none
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glucose depletion; the current choice (TEF1pr) still shows
some decreased activity under glucose depletion or high
ethanol (see Figure 1D, as well as Figures S1 and S4). In this
way, the entire pathway would only be activated when
suﬃcient biomass has accumulated and PCA is given no
time to accumulate and be secreted, as seen in the strain
designs tested here. Testing diﬀerent CSREs in synthetic
promoters would also allow us to select more promoters for
every gene in the pathway in future conﬁgurations. Ultimately,
it may be advantageous to have a combination of CSREs
(native or synthetic) and glycolytic TFBSs to modulate
expression across glucose concentrations. Such a conﬁguration
would be beneﬁcial in fermentations where glucose levels are
low or periodically replenished, such as a fed-batch cultivation.
The promoters that have been engineered and put to use in
this study reaﬃrm our promoter engineering strategy,14 which
does not require altered transcription factor expression, or
orthogonal regulatory systems.33−35 We can foresee such
synthetic promoters being designed as needed, or used oﬀ-the-
shelf in other applications where the bulk of products are made
during ethanol consumption phases, when a product or
enzyme is toxic to the cell and decoupling production from
growth is potentially beneﬁcial, or where multiple carbon
sources are being used.30,36,37 The last application is of interest
for our promoters, because they also show strong induction
when grown in ethanol (see Figure S4). Our current promoters
were mainly engineered by replacing TFBSs in known
promoter architectures, but we expect future engineering
eﬀorts to more explicitly and optimally space regulatory
elements in both the upstream activation/repressive elements
and core promoters.38−41 Since promoters for cell factories
may not require induction at the diauxic phase, future
engineering eﬀorts will focus on ﬁnding an optimal balance
and conﬁguration of glycolytic, diauxic, and gluconeogenic
transcription factors and their binding sites to achieve
constitutively high expression levels ultimately supporting the
rational design of next-generation, high-performance yeast cell
factories.
■ MATERIALS AND METHODS
Reporter Strain Construction. S. cerevisiae CEN.PK 113-
7D was used as background strain for all experiments.
Promoters were ampliﬁed from genomic DNA or gBlocks
(IDT) using Phusion Master Mix with HF buﬀer (Thermo-
Fisher). YFP and resistance markers were ampliﬁed from
plasmid pASR0130.12 YFP expression cassettes with diﬀerent
promoters were cloned into the EasyClone site XII-4 using in
vivo assembly by homologous recombination. In brief, 500
pmol of the relevant promoter, YFP, the VPS13 terminator,
and kanMX cassette for G418 resistance marker were
transformed to yeast with 500 bp of homology to XII-4 on
either end by the lithium acetate method onto YPD agar with
350 ng/μL G418. Parts used in assembly had 50 bp homology
with adjacent parts added by PCR. G418-resistant colonies
were screened by multiplex colony PCR as previously
described,42 checking for integration and assembly at the
correct locus. Colonies with sequence-veriﬁed reporter
constructs were streaked out on YPD agar, regrown in YPD
with 200 ng/μL G418 and preserved as glycerol stocks. All
primers used for strain construction are listed in Table S3, and
all constructed strains are listed in Table S4.
Figure 2. Benchmarking vanillin-β-glucoside production in yeast using synthetic gluconeogenic promoters. (A) Vanillin-β-glucoside pathway
overview (left) and layout of promoter usage in control C-VG strain,30 and strains ScASR.V001 and ASR.V003 engineered with using synthetic
gluconeogenic promoters (right). Starting from the shikimate pathway, the vanillin-β-glucoside pathway is marked in green. (B) Vanillin-β-
glucoside production during 65 h cultivations in 5-mL-deep well plates. Data represent two independent biological replicates samples. (C)
Representative growth proﬁles of vanillin-β-glucoside production strains C-VG, ScASR.V001, and ScASR.V003 cultivated in duplicates in 250-mL
shake ﬂasks. Mean growth rates ± the standard deviation (SD) from duplicate measurement are inserted (D) Pie charts illustrating average relative
distribution of the pathway products for each strain, as a percentage of the total products of the vanillin-β-glucoside pathway. The average
metabolite distribution is based on two biological replicates sampled at the end of 65 h fermentations (see panel (B), as well as Figure S7).
[Abbreviations: PCA, protocatechuic acid; PAL, protocatechuic aldelyde; VAC, vanillic acid; VAN, vanillin; and VG, vanillin-β-glucoside.] For
panels (B)−(D), growth curves, growth rates, and metabolite proﬁles from individual cultivations can be found in Figures S6−S8.
ACS Synthetic Biology Technical Note
DOI: 10.1021/acssynbio.9b00027
ACS Synth. Biol. 2019, 8, 1462−1468
1465
YFP Reporter Assays. Reporter strains, as well as the
background strain, were grown overnight in synthetic drop-out
medium minus leucine (SD-leu, Sigma) containing 1.1 g/L
monosodium glutamate as a carbon source and 200 ng/μL
G418 where appropriate. These were diluted to an OD of
∼0.02 in minimal Delft medium,43 pH 6 and grown at 30 °C in
deep-well microtiter plates with 300 rpm agitation. The culture
was sampled at 4, 8, 24, 48, 72, and 96 h for measuring YFP
ﬂuorescence by ﬂow cytometry. Cells were suitably diluted in
phosphate-buﬀered saline (PBS) (Life Technologies) and their
ﬂuorescence measured on an LSRFortessa ﬂow cytometer (BD
Biosciences) equipped with an HTS module for sampling. YFP
ﬂuorescence was measured with 488 nm excitation and 530 nm
emission. A total of 10 000 events per sample were acquired
using FACSDiva software, and the resulting FCS ﬁles were
analyzed using the FCSExtract utility (http://research.stowers.
org/mcm/efg/ScientiﬁcSoftware/Utility/FCSExtract/index.
htm), R scripts and Origin 9.1 (OriginLab) to extract the mean
population ﬂuorescence. Alternatively, the cells sampled at the
same time points and diluted in PBS had their OD and YFP
ﬂuorescence (488 nm excitation and 527 nm emission)
measured on a SynergyMX microtiter plate reader using
clear-bottomed black microtiter plates (Thermoﬁsher), and
ﬂuorescence values normalized to sample OD following the
subtraction of background ﬂuorescence from CEN.PK 113-7D.
A qualitative estimate of residual glucose was determined using
test strips (VWR) at each sampling point.
Vanillin-β-Glucoside Production Strains. The ﬁve-gene
vanillin-β-glucoside biosynthetic pathway (Figure 2A) was
introduced using CasEMBLR42 into three loci: BGL1/EXG1
and ADH6, to simultaneously knock these genes out and
thereby avoid product degradation,29,30 and the EasyClone site
XII-5.43 The pathway was integrated into the genome in two
steps. In the ﬁrst reaction, 4 pmol of each part (insertion
homology arms, promoters, terminators, and genes (ACAR
and EntD)) were co-transformed with a gRNA expression
plasmid targeting ADH6 (clonNAT resistance) into CEN.PK
113-7D already carrying a Cas9 expression plasmid (G418
resistant). Following genotyping of transformants and
sequence veriﬁcation of the assemblies, colonies with correctly
assembled and integrated expression cassettes were cured for
loss of the ADH6 plasmid and subsequently transformed with a
gRNA plasmid targeting EXG1 and site XII-5, along with parts
for expression cassettes of OMT, UGT, and 3-DSD. Colonies
were screened as done previously, and those containing all ﬁve
genes of the pathway successfully integrated and assembled
were retained for fermentations. Figure S5 gives the layout of
the pathway integration and the genotyping assays. The gRNA
plasmids are listed in Table S5 in the Supporting Information.
Bioreactor Cultures and HPLC Analysis of Metabo-
lites. For the transcriptome analysis, an overnight culture of
log-phase S. cerevisiae grown in Delft medium was inoculated
into a 500 mL Delft medium at a starting OD of 0.03. The
cultures were carried out in 1L Biostat Q bioreactors
(Sartorius) in triplicate at 30° with 800 rpm agitation, with
controlled aeration and pH maintained at 6 using 2 M NaOH.
Fermentation broth was sampled every 2 h for the monitoring
of OD, and glucose and yeast metabolites by high-performance
liquid chromatography (HPLC). For the latter, the broth
sample was centrifuged at 10 000g for 2 min, and the
supernatant was syringe-ﬁltered using a 0.22 μm syringe ﬁlter.
These were diluted 2-fold or 5-fold for HPLC analysis
(UltiMate 3000, Dionex) as previously described,44 and data
acquired and analyzed using Chromeleon (Dionex/Thermo-
ﬁsher). For the cultivations of the vanillin-β-glucoside
production strains, a single colony of each of the vanillin-β-
glucoside production strains C-VG, ScASR.V001 and
ScASR.V003 were picked from a YPD plate to inoculate a
culture in Delft medium. Overnight cultures were used as
inoculum to start duplicate cultures of each strain in Delft
medium at pH 6.0 in 250 mL shake ﬂasks with a starting
OD600 nm of ∼0.2. Growth rates were calculated based on
OD600 nm measurements in the exponential growth phase (see
Figure S6 in the Supporting Information). For the metabolite
proﬁle of vanillin-β-glucoside and precursors, the strains were
cultivated in duplicates in 24-deep well plates using 5 mL Delft
medium at pH 6.0 (Figure S8). The respective cultures were
inoculated at a starting OD600 nm of ∼0.04 with a previously
prepared overnight culture, and OD600 nm measured during the
course of the cultivation by means of plate reader
(SynergyMX). Samples taken at regular time intervals were
extracted and quantiﬁed by HPLC, as previously described.30
For glucose and ethanol quantiﬁcations, samples taken during
cultivations were centrifuged for 5 min at 13 000 rpm and 4
°C. Thereafter, 20 μL of the supernatants were analyzed using
an Aminex HPX-87H column (Bio-Rad) in an Ultimate 3000
HPLC system (ThermoFisher Scientiﬁc) with a refractive
index detector (RI-101 Refractive Index Detector, Shodex)
(see Figure S7). The column was set at 45 °C and eluted with
5 mM H2SO4 at a ﬂow rate of 0.6 mL min
−1, as previously
described.45
RNaseq and Transcriptome Data Analysis. Thirty (30)
OD units of bioreactor yeast culture grown in 6, 14, and 26 h
were harvested for total RNA extraction, the time points
corresponding to at lag/early log phase, mid-log phase ,and
late-log phase/diauxic shift. Sampling points were determined
from trends in growth curves. Cells were harvested from
fermentation broth in chilled 15 mL centrifuge tubes half-ﬁlled
with ice, and then the total RNA was extracted, as previously
described using the RNeasy Mini kit (Qiagen).46 RNA
concentration and quality control were performed using a
Qubit 2.0 ﬂuorometer (Life Technologies) and an Agilent
2100 Bioanalyzer with RNA 6000 Nano kit, respectively
(Agilent). RNaseq was performed as previously described.47
TopHat (2.0.14) and the Cuﬄinks (2.2.1) suite were
employed for RNaseq analysis, as described previously,48
using the reference genome and annotations for S. cerevisiae
S288C (NCBI RefSeq GCF_000146045.2). Three biological
replicates were used to determine expression levels (Fragments
Per Kilobase of exon per Million fragments mapped; FPKM)
for each condition. Upper-quartile normalization was preferred
and reads mapping to rRNA genes were masked. Cuﬀdiﬀ is
used to obtain fold change diﬀerences and to perform
statistical testing. A q-value cutoﬀ of <0.05 was used to
identify genes that have signiﬁcant diﬀerential expression
(Table S1). GO and GO_slim mappings were retrieved from
the Saccharomyces Genome Database (http://www.
yeastgenome.org). When extraction was not possible due to
chromosome ends, the largest possible sequence ﬁtting the
criteria was used. For transcription factor binding site analysis
of CSRE, sequences spanning −700 bp to −125 bp upstream
from CDS features (or largest possible sequence ﬁtting the
criteria) were extracted and patterns matching those listed in
Table S2 were identiﬁed using biopython (Version 1.68).
Database for RNA-seq Data. RNA-seq data have been
deposited in the ArrayExpress database at EMBL-EBI (www.
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ebi.ac.uk/arrayexpress), under accession number E-MTAB-
7657 (also see Table S1).
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